Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical Care
September 06, 2024
Eversheds Sutherland advises Edwards Lifesciences on its US$4.2bn sale of Critical CareSeptember 06, 2024 Eversheds Sutherland has advised Edwards Lifesciences on the US$4.2bn sale of its Critical Care product group to Becton, Dickinson and Company (BD). Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease. The Critical Care product group is an industry leader in advanced patient monitoring with advanced AI algorithms serving millions of patients globally. Key contacts
Lee Harris Partner United Kingdom Antony Walsh Partner United Kingdom Barri Mendelsohn Partner United Kingdom Rachel Cooper Partner United Kingdom Edward M. Tompkin-Haag Partner United Kingdom Kelly Holmes Partner United Kingdom Philip Crosbie Partner United Kingdom Christopher Murray Partner United Kingdom Latest Insights
Latest News
Latest Events
legal updates October 08, 2026 The Commercial Payments Bill: Practical Implications for Commercial Contrac... legal updates October 07, 2026 EU: Proposed KIDS Act Targets Online Child Safety legal updates October 07, 2026 Commercially Connected Shorts - 7 October 2026 guides and reports October 07, 2026 Technology, AI and the changing legal landscape of M&A firm news October 07, 2026 Faster deals, deeper diligence: AI is transforming the legal landscape of M... firm news October 05, 2026 Leading finance partner joins Eversheds Sutherland firm news October 01, 2026 Eversheds Sutherland Switzerland appoints Dr. Michael Faske as new Partner firm news October 01, 2026 Eversheds Sutherland Switzerland appoints Dr. Markus Wyssling as a new Part... virtual Immigration UK – Right to work and compliance masterclass October 15, 2026 9.30am - 12.30pm (GMT) Virtual virtual German employment law training October 20, 2026 2pm - 5pm (GMT) Virtual in-person Case Study & Apéro October 28, 2026 17:00 - 18:45 Bern, Switzerland virtual French employment law training November 03, 2026 2pm - 5pm (GMT) Virtual |